Akhil Srivastava
Affiliations: | University of Hawai'i at Manoa, Honolulu, HI |
Area:
Fungal pathogenesis and geneticsGoogle:
"Akhil Srivastava"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chinnappan M, Srivastava A, Amreddy N, et al. (2020) Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs. Cancer Letters |
| Srivastava A, Amreddy N, Razaq M, et al. (2018) Exosomes as Theranostics for Lung Cancer. Advances in Cancer Research. 139: 1-33 |
| Andrade D, Mehta M, Griffith J, et al. (2017) YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways. Oncotarget. 8: 98495-98508 |
| Amreddy N, Babu A, Panneerselvam J, et al. (2017) Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment. Nanomedicine : Nanotechnology, Biology, and Medicine |
| Muralidharan R, Babu A, Amreddy N, et al. (2017) Tumor-targeted nanoparticle delivery of HuR siRNA inhibits lung tumor growth in vitro and in vivo by disrupting the oncogenic activity of the RNA-binding protein HuR. Molecular Cancer Therapeutics |
| Srivastava A, Amreddy N, Babu A, et al. (2016) Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells. Scientific Reports. 6: 38541 |
| Panneerselvam J, Srivastava A, Muralidharan R, et al. (2016) IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells. Oncotarget |
| Srivastava A, Babu A, Filant J, et al. (2016) Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer. Journal of Biomedical Nanotechnology. 12: 1159-73 |
| Panneerselvam J, Srivastava A, Muralidharan R, et al. (2016) Abstract 3738: IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells Cancer Research. 76: 3738-3738 |
| Muralidharan R, Amreddy N, Babu A, et al. (2016) 489. Tumor-Targeted Hursirna-Nanoparticle Delivery Inhibits Lung Tumor Growth In Vitro and In Vivo Molecular Therapy. 24: S194 |